We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Interface
TILE
$2.05B
| $47.8K | ﹤0.01% |
1,653
+1,028
| +164% | +$25.9K |
|
1852
Arm
ARM
$296B
| $47.8K | ﹤0.01% |
+338
| New | +$49.2K |
|
1853
Rocket Companies
RKT
$38.9B
| $47.6K | ﹤0.01% |
2,455
+1,932
| +369% | +$33.7K |
|
1854
Movado Group
MOV
$867M
| $47K | ﹤0.01% |
+2,477
| New | +$42.9K |
|
1855
Vuzix
VUZI
$215M
| $47K | ﹤0.01% |
+15,000
| New | +$35.4K |
|
1856
Oric Pharmaceuticals
ORIC
$1.33B
| $46.9K | ﹤0.01% |
+3,906
| New | +$41.1K |
|
1857
Maplebear
CART
$10.6B
| $46.7K | ﹤0.01% |
1,270
+1,115
| +719% | +$51.3K |
|
1858
Green Brick Partners
GRBK
$3.15B
| $46.7K | ﹤0.01% |
632
+537
| +565% | +$36.7K |
|
|
LB
1859
LandBridge Co
LB
$2.11B
| $46.5K | ﹤0.01% |
871
+19
| +2% | +$1.05K |
|
1860
Vanguard Consumer Discretionary ETF
VCR
$6.29B
| $46.4K | ﹤0.01% |
117
+116
| +11,600% | +$44.2K |
|
1861
Allogene Therapeutics
ALLO
$666M
| $46.4K | ﹤0.01% |
+37,401
| New | +$44.6K |
|
1862
Phreesia
PHR
$707M
| $46.3K | ﹤0.01% |
1,970
+1,877
| +2,018% | +$51K |
|
1863
Titan International
TWI
$473M
| $46.2K | ﹤0.01% |
6,110
+5,326
| +679% | +$47.5K |
|
1864
Old National Bancorp
ONB
$10.3B
| $46.2K | ﹤0.01% |
2,104
-3,945
| -65% | -$87.2K |
|
1865
Sprinklr
CXM
$1.56B
| $45.9K | ﹤0.01% |
5,940
+5,638
| +1,867% | +$47.5K |
|
|
LADR
1866
Ladder Capital
LADR
$1.21B
| $45.7K | ﹤0.01% |
+4,191
| New | +$47.2K |
|
1867
Construction Partners
ROAD
$6.03B
| $45.7K | ﹤0.01% |
360
+26
| +8% | +$2.97K |
|
1868
Invesco S&P MidCap Momentum ETF
XMMO
$7.44B
| $45.7K | ﹤0.01% |
+338
| New | +$44.5K |
|
1869
Cinemark Holdings
CNK
$4.42B
| $45.6K | ﹤0.01% |
+1,626
| New | +$44.9K |
|
1870
Intellia Therapeutics
NTLA
$1.53B
| $45.5K | ﹤0.01% |
2,635
+2,534
| +2,509% | +$31.2K |
|
1871
TrueShares Structured Outcome April ETF
APRZ
$33.5M
| $45.3K | ﹤0.01% |
+1,194
| New | +$43.8K |
|
1872
RPC Inc
RES
$1.29B
| $45.3K | ﹤0.01% |
+9,525
| New | +$45K |
|
1873
Krystal Biotech
KRYS
$9.56B
| $45.2K | ﹤0.01% |
256
+250
| +4,167% | +$37.4K |
|
1874
Coherent
COHR
$65.2B
| $45.1K | ﹤0.01% |
419
-263
| -39% | -$26.2K |
|
1875
Fox Factory Holding Corp
FOXF
$823M
| $44.9K | ﹤0.01% |
1,849
+1,100
| +147% | +$31K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.